Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel blood test for the early detection of oral, prostate and breast cancer

30.01.2014
The likelihood for successful treatment of a cancer is fundamentally linked to an early diagnosis of the condition.

For this, it is essential to provide tests that allow early detection of cancer without the need of a tissue sample, and thus drastically improve the prognosis of the patients and their chance of a cure. Currently established cancer diagnostics either identify the disease too late or are unreliable, resulting in false positives, which can unsettle patients.

For instance, measuring PSA-levels for prostate cancer detection and mammographies for breast cancer prevention can provide false positive results without acute malignancies being found. Additionally, currently no blood test is available for oral cancer.

A novel blood test for the detection of cancer has been clinically assessed in a collaborative study between the university hospital Tuebingen, the German Cancer Research Center in Heidelberg, and the Clemenshospital of the university hospital muenster. This blood test utilizes the immune system; specifically the activity of macrophages, a type of white blood cell that scavenges tumor cells.

Using laser-based detection methods of tumor material within these scavenger cells, also known as EDIM (epitope detection in monocytes)-technology, it is now possible to discover the presence of tumor cells in small blood samples. This has allowed the early detection of oral, prostate, and breast cancer as well as relapses in patients by the EDIM-technology. Thus, this technology is also suitable for monitoring therapeutic efficacy. The results of this study represent an important hallmark in cancer detection, driven by the improved accuracy of the EDIM-blood test compared to previously established test methodologies.

publication

A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells
Martin Grimm, Steffen Schmitt, Peter Teriete, Thorsten Biegner, Arnulf Stenzl, Jörg Hennenlotter, Hans-Joachim Muhs, Adelheid Munz, Tatjana Nadtotschi, Klemens König, Jörg Sänger, Oliver Feyen, Heiko Hofmann, Siegmar Reinert and Johannes F Coy
BMC Cancer 2013, 13:569 - doi:10.1186/1471-2407-13-569
Quelle: http://www.biomedcentral.com/1471-2407/13/569
Contact
Universitätsklinikum Tübingen
Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie
Priv.-Doz. Dr. Dr. Martin Grimm
Osianderstr. 2-8, 72076 Tübingen
E-Mail: Martin.Grimm@med.uni-tuebingen.de

Dr. Ellen Katz | idw
Further information:
http://www.uni-tuebingen.de

More articles from Health and Medicine:

nachricht New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
20.08.2014 | University of California - Los Angeles Health Sciences

nachricht Seafood substitutions can expose consumers to unexpectedly high mercury
20.08.2014 | University of Hawaiʻi at Mānoa

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Mathematics and Computer Science - Key Disciplines in Developing Countries as well?

20.08.2014 | Event News

5th Technical Conference "Subsoil Analysis, Ground Improvement and Wind Turbine Foundations"

13.08.2014 | Event News

Consumer Research - ICCR 2014

07.08.2014 | Event News

 
Latest News

Electrical engineers take major step toward photonic circuits

20.08.2014 | Materials Sciences

NASA Sees Tropical Storm Lowell's Tough South Side

20.08.2014 | Earth Sciences

Why global warming is taking a break

20.08.2014 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>